Article

Speaking of Studies

Learn the terminology to decipher research studies

Absolute risk: The risk of developing a disease over a specific period of time.

Complete response: Disappearance of all signs of cancer as a result of treatment; does not always equate to a cure.

Disease-free survival: Length of time after treatment during which no evidence of cancer is found.

Five-year survival: The percentage of patients in a population who have survived at least five years. Five years is the standard for most cancers when discussing survival.

Mean: The average of a group of numbers.

Median: The middle number(s) in a group.

Partial response: Tumor shrinkage by at least 30 percent.

Progression: Spreading or growing disease (by at least 20 percent), with or without treatment.

Progression-free survival: The length of time a patient has survived without growth of the cancer.

Relative risk: The risk of disease in an affected (exposed) group compared with a control (unexposed) group.

Stable disease: The cancer is neither growing nor shrinking.

Adapted with permission of the American Cancer Society.

Related Videos
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
1 expert is featured in this series.
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
1 expert is featured in this series.
Image of man with grey hair.
Image of woman with blonde hair.
Image of man with grey hair.
Related Content